BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17823042)

  • 1. Experimental study of a new vascular graft prebonded with antibiotic: healing, toxicity, and antibiotic retention.
    Javerliat I; Goëau-Brissonnière O; Bruneval P; Coggia M
    Ann Vasc Surg; 2007 Sep; 21(5):603-10. PubMed ID: 17823042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
    Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
    J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system.
    Chervu A; Moore WS; Gelabert HA; Colburn MD; Chvapil M
    J Vasc Surg; 1991 Oct; 14(4):521-4; discussion 524-5. PubMed ID: 1833564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts.
    Gahtan V; Esses GE; Bandyk DF; Nelson RT; Dupont E; Mills JL
    J Surg Res; 1995 Jan; 58(1):105-10. PubMed ID: 7830398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of early graft infection with rifampicin-bonded Gelseal grafts: a multicentre experimental study.
    D'Addato M; Curti T; Freyrie A; Agus GB; Bertini D; Biasi G
    Cardiovasc Surg; 1994 Apr; 2(2):254-8. PubMed ID: 8049957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study.
    Knosalla C; Goëau-Brissonnière O; Leflon V; Bruneval P; Eugène M; Pechère JC; Koskas F; Nicolas MH; Leschi JP; Gerota J; Kieffer E
    J Vasc Surg; 1998 Apr; 27(4):689-98. PubMed ID: 9576083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group.
    Braithwaite BD; Davies B; Heather BP; Earnshaw JJ
    Br J Surg; 1998 Oct; 85(10):1378-81. PubMed ID: 9782018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gelweave polyester arterial prosthesis.
    Ukpabi P; Marois Y; King M; Deng X; Martin L; Laroche G; Douville Y; Guidoin R
    Can J Surg; 1995 Aug; 38(4):322-31. PubMed ID: 7634198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of healing characteristics of DALLON-standard and DALLON-double velour vascular prostheses].
    Zimnoch L; Głowiński S; Andrzejewska A; Raczyński K; Kondracki S; Głowiński J
    Polim Med; 1992; 22(4):43-62. PubMed ID: 1305966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft.
    Lachapelle K; Graham AM; Symes JF
    J Vasc Surg; 1994 Apr; 19(4):675-82. PubMed ID: 8164283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elution of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins.
    Galdbart JO; Branger C; Andreassian B; Lambert-Zechovsky N; Kitzis M
    J Surg Res; 1996 Dec; 66(2):174-8. PubMed ID: 9024831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft.
    Goëau-Brissonnière O; Leport C; Bacourt F; Lebrault C; Comte R; Pechère JC
    Ann Vasc Surg; 1991 Sep; 5(5):408-12. PubMed ID: 1835641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small diameter vascular prostheses with incorporated bioabsorbable matrices. A preliminary study.
    Niu S; Kurumatani H; Satoh S; Kanda K; Oka T; Watanabe K
    ASAIO J; 1993; 39(3):M750-3. PubMed ID: 8268638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experimental study of the healing of velour grafts].
    Kobayashi O
    Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):211-9. PubMed ID: 3713674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental studies of vascular prostheses made of plastics with antibacterial properties].
    Sowiński A; Andruszeniec R; Lesiakowska K; Lipnicki D; Okrojek C; Noszczyk W
    Polim Med; 1985; 15(3-4):99-108. PubMed ID: 3835548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascugraft microporous polyesterurethane arterial prosthesis as a thoraco-abdominal bypass in dogs.
    Marois Y; Pâris E; Zhang Z; Doillon CJ; King MW; Guidoin RG
    Biomaterials; 1996 Jul; 17(13):1289-300. PubMed ID: 8805976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections.
    Colburn MD; Moore WS; Chvapil M; Gelabert HA; Quiñones-Baldrich WJ
    J Vasc Surg; 1992 Oct; 16(4):651-8; discussion 658-60. PubMed ID: 1344030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental evaluation of two-sided velour vascular prostheses of Polish production].
    Zalech H; Sołtysiak A; Serafin B
    Polim Med; 1984; 14(1-4):27-36. PubMed ID: 6533633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft.
    Shue WB; Worosilo SC; Donetz AP; Trooskin SZ; Harvey RA; Greco RS
    J Vasc Surg; 1988 Nov; 8(5):600-5. PubMed ID: 2972845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of cathepsin D activity of DALLON-standard and DALLON-double velour grafts implanted into the abdominal aorta].
    Głowiński S; Worowski K; Raczyński K
    Polim Med; 1992; 22(4):63-8. PubMed ID: 1305967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.